Literature DB >> 32470089

A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda.

Gabriel Chamie1, Alex Ndyabakira2, Kara G Marson1, Devy M Emperador1, Moses R Kamya3, Diane V Havlir1, Dalsone Kwarisiima4, Harsha Thirumurthy5.   

Abstract

BACKGROUND: Retesting for HIV is critical to identifying newly-infected persons and reinforcing prevention efforts among at-risk adults. Incentives can increase one-time HIV testing, but their role in promoting retesting is unknown. We sought to test feasibility and acceptability of incentive strategies, including commitment contracts, to promote HIV retesting among at-risk adults in rural Uganda.
METHODS: At-risk HIV-negative adults were enrolled in a pilot trial assessing feasibility and acceptability of incentive strategies to promote HIV retesting three months after enrollment. Participants were randomized (1:1:3) to: 1) no incentive; 2) standard cash incentive (~US$4); and 3) commitment contract: participants could voluntarily make a low- or high-value deposit that would be returned with added interest (totaling ~US$4 including the deposit) upon retesting or lost if participants failed to retest. Contracts sought to promote retesting by leveraging loss aversion and addressing present bias via pre-commitment. Outcomes included acceptability of trial enrollment, contract feasibility (proportion of participants making deposits), and HIV retesting uptake.
RESULTS: Of 130 HIV-negative eligible adults, 123 (95%) enrolled and were randomized: 74 (60%) to commitment contracts, 25 (20%) to standard incentives, and 24 (20%) to no incentive. Of contract participants, 69 (93%) made deposits. Overall, 93 (76%) participants retested for HIV: uptake was highest in the standard incentive group (22/25 [88%]) and lowest in high-value contract (26/36 [72%]) and no incentive (17/24 [71%]) groups.
CONCLUSION: In a randomized trial of strategies to promote HIV retesting among at-risk adults in Uganda, incentive strategies, including commitment contracts, were feasible and had high acceptability. Our findings suggest use of incentives for HIV retesting merits further comparison in a larger trial. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT:02890459.

Entities:  

Year:  2020        PMID: 32470089     DOI: 10.1371/journal.pone.0233600

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

1.  Financial Incentives, Not Behavioral Nudges, Led to Optimized HIV Testing among Pregnant Women in a High-Burden Urban Population in Ecuador.

Authors:  Miguel Reina Ortiz; Michelle Grunauer; Erika Gutierrez; Ricardo Izurieta; Mario Macis; Phillip Phan; Carlos Rosas; Enrique Teran
Journal:  Am J Trop Med Hyg       Date:  2022-04-11       Impact factor: 3.707

2.  Promised and Lottery Airtime Incentives to Improve Interactive Voice Response Survey Participation Among Adults in Bangladesh and Uganda: Randomized Controlled Trial.

Authors:  Dustin Garrett Gibson; Gulam Muhammed Al Kibria; George William Pariyo; Saifuddin Ahmed; Joseph Ali; Alain Bernard Labrique; Iqbal Ansary Khan; Elizeus Rutebemberwa; Meerjady Sabrina Flora; Adnan Ali Hyder
Journal:  J Med Internet Res       Date:  2022-05-09       Impact factor: 7.076

3.  Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial.

Authors:  Gabriel Chamie; Dalsone Kwarisiima; Alex Ndyabakira; Kara Marson; Carol S Camlin; Diane V Havlir; Moses R Kamya; Harsha Thirumurthy
Journal:  PLoS Med       Date:  2021-05-04       Impact factor: 11.069

Review 4.  Applying Behavioural Insights to HIV Prevention and Management: a Scoping Review.

Authors:  Alexsandra Andrawis; James Tapa; Ivo Vlaev; Daniel Read; Kelly Ann Schmidtke; Eric P F Chow; David Lee; Christopher K Fairley; Jason J Ong
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-05       Impact factor: 5.495

5.  Financial Incentives for Pediatric HIV Testing (FIT): Caregiver Insights on Incentive Mechanisms, Focus Populations, and Acceptability for Programmatic Scale Up.

Authors:  Junyi Zhang; Dana L Atkins; Anjuli D Wagner; Irene N Njuguna; Jillian Neary; Vincent O Omondi; Verlinda A Otieno; Winnie O Atieno; Merceline Odhiambo; Dalton C Wamalwa; Grace John-Stewart; Jennifer A Slyker; Bryan J Weiner; Kristin Beima-Sofie
Journal:  AIDS Behav       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.